《Table 1 Clinicohistopathological summary of patients with urothelial carcinoma of bladder》

《Table 1 Clinicohistopathological summary of patients with urothelial carcinoma of bladder》   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/β-catenin in urinary bladder cancer patients》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录
UCB:Urothelial carcinoma of bladder;SCC:Squamous cell carcinoma;TURBT:Transurethral resection of bladder;NMIBC:Non-muscle invasive bladder cancer;MIBC:Muscle invasive bladder cancer.

Out of the total 90 tumors examined,28(31.1%)tumors co-expressed altered protein levels of pS9GSK-3βandβ–Catenin proteins(Figure 2C).These proteins were observed to be aberrantly co-expressed in 67.9%(19/28)muscle invasive tumors(P=0.01;Mann Whitney U test);78.6%(22/28)high grade tumors;60.7%(17/28)recurrent tumors(P=0.02;Mann Whitney test);60.7%(17/28)frequent smokers/tobacco chewers and 82.1%(23/28)tumors from hematuric patients(P=0.04;Mann Whitney U test)(Table 3) .